| 5.1 -1.09 (-17.61%) | 01-17 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10.75 | 1-year : | 14.58 |
| Resists | First : | 9.2 | Second : | 12.48 |
| Pivot price | 5.91 |
|||
| Supports | First : | 3.9 | Second : | 3.24 |
| MAs | MA(5) : | 6.27  |
MA(20) : | 5.68 |
| MA(100) : | 19.5 |
MA(250) : | 131.01 |
|
| MACD | MACD : | -1 |
Signal : | -1.4 |
| %K %D | K(14,3) : | 20.1 |
D(3) : | 24.5 |
| RSI | RSI(14): 41.2 |
|||
| 52-week | High : | 581.84 | Low : | 3.9 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ XXII ] has closed above bottom band by 27.0%. Bollinger Bands are 79% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6.51 - 6.54 | 6.54 - 6.57 |
| Low: | 4.93 - 4.97 | 4.97 - 5 |
| Close: | 5.05 - 5.1 | 5.1 - 5.15 |
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Fri, 17 Jan 2025
22nd Century Group (NASDAQ: XXII) and Smoker Friendly Forge New Agreement – Market - HPBL
Tue, 14 Jan 2025
22nd Century Group Stock Rises On Proposed FDA Mandate On Nicotine Content: Retail's Extremely Bullish - MSN
Mon, 13 Jan 2025
XXII - 22nd Century Group Inc. Latest Stock News & Market Updates - StockTitan
Mon, 13 Jan 2025
22nd Century ready to support FDA's reduced nicotine cigarette policy, stock up 30% - Seeking Alpha
Mon, 13 Jan 2025
22nd Century Group Ready to Lead FDA's Reduced Nicotine Cigarette Revolution with VLN Brand - StockTitan
Tue, 07 Jan 2025
22nd Century Group Expands Smoker Friendly Partnership with Premium Brand Launch, 5-Year Deal - StockTitan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Tobacco
|
|
| Shares Out | 0 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 1.037e+007 (%) |
| Held by Institutions | 14.3 (%) |
| Shares Short | 2 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -56.8 % |
| Return on Assets (ttm) | -23.4 % |
| Return on Equity (ttm) | 362.8 % |
| Qtrly Rev. Growth | -61 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.21 |
| EBITDA (p.s.) | -0.39 |
| Qtrly Earnings Growth | 419.2 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -15 (M) |
| PE Ratio | -2.55 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 23.83 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 4460 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|